2100 electrophoresis bioanalyzer
Ended Awarded Last action
- Contract number
- HHSF223201400715G
- Awardee
-
Agilent Technologies, Inc. UEI EH1RW7J692F6 Part of Agilent Technologies, Inc.
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $21,933
Award facts
- Opportunity
-
- Scientific Equipment and Services Solicitation · 7FCBC4070066B · Posted Jun 13, 2019
- Contract value 100% obligated
- $21,932.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Atlanta, GA 30309, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on September 11, 2014, awards $21,932.99 to Agilent Technologies, Inc. (Santa Clara Site division) for the procurement of a 2100 Electrophoresis Bioanalyzer. The award was made by the Food and Drug Administration under the General Services Administration's Scientific Equipment and Services schedule (FSS-66), which streamlines the procurement of specialized laboratory instrumentation. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating full and open competition. Performance is specified for Atlanta, Georgia, with a completion date of October 13, 2014.
The 2100 Electrophoresis Bioanalyzer is a specialized analytical instrument used in laboratory environments for bioanalytical applications, consistent with Agilent's core business of providing scientific equipment and solutions to federal agencies. This delivery order represents a continuation of Agilent's substantial presence in the federal market, where the company has supplied diverse analytical instrumentation, diagnostic equipment, and related services to multiple agencies including the Department of Health and Human Services, Department of Energy, and the Drug Enforcement Administration. The FDA's acquisition through the GSA schedule vehicle demonstrates the efficiency of leveraging established commercial contracts for routine scientific equipment purchases supporting the agency's regulatory and analytical missions.
Quick answers
Who was awarded contract HHSF223201400715G?
HHSF223201400715G was awarded to Agilent Technologies, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 11, 2014.
How much is contract HHSF223201400715G worth?
The government has obligated $21,933 on HHSF223201400715G.
Is contract HHSF223201400715G an order under another contract?
Yes. HHSF223201400715G is a delivery order under GS07F0564X, a federal supply schedule, on Scientific Equipment and Services (FSS-66).
Was contract HHSF223201400715G competed?
The extent of competition for HHSF223201400715G was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award